$WT

WisdomTree, Inc. Q2 2026 Earnings Call Summary

WisdomTree, Inc. reported a sixth straight quarter of record AUM at $162.9 billion and adjusted operating margins up 900 bps to 41.1%. Management said it expects about 15 new ETFs in 18 months, continued share repurchases, and revised interest income guidance to $8 million from $10 million.

Original reporting
Published Aug 2, 2026, 4:15 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 2, 2026, 4:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
WisdomTree, Inc. Q2 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$WTNeutralMed
01

Why it matters

Traders can update H2 earnings expectations using the revised interest income guidance and the stated diluted share count range, while also monitoring execution risk around Atlantic House fee timing and regulatory progress for tokenized ETFs.

02

Market read

The call provides actionable forward-looking inputs (interest income guide cut, share count assumptions) and execution milestones (15 new ETFs, tokenized ETF filing) that can reprice near-term earnings and longer-term growth optionality.

03

What to watch

Atlantic House structuring fees are described as sporadic and dependent on launch timing, which can make quarterly revenue less predictable than the AUM and margin narrative suggests.

Relevance 6/10Novelty 6/10Timing: ahead of H2 execution, with guidance assumptions for diluted share count and interest income

Background

WisdomTree’s Q2 2026 earnings call emphasizes record AUM, margin expansion, and strategic expansion through the Atlantic House acquisition, alongside a tokenization platform roadmap.

Company-level read

Ticker impact

$WTNeutralMedium confidence
Context

WisdomTree guided H2 interest income to $8M from $10M and reiterated buybacks, tokenized ETF pipeline, and Atlantic House fee volatility.

Expected impact

Near-term downside risk from the reduced interest income guide, partially offset by buyback emphasis and incremental ETF/tokenization catalysts.

Evidence & confidence

The article provides specific forward-looking financial guidance (interest income) and concrete operational plans (15 new ETFs, tokenized ETF filing), which can shift expectations for H2 earnings power and capital return timing.

Market effects

Highlights ongoing regulatory uncertainty for tokenized products and potential competitive pressure in ETF launches and tokenization platforms.

Emphasizes expansion from UK into U.S. and Europe via Atlantic House, which could affect regional product mix and fee structures.

Tokenization and private-markets distribution themes remain globally relevant, but the article’s specifics are company-execution focused.

Counterpoint

The tokenization and new-ETF pipeline may be longer-dated than the market expects, so the near-term earnings guide cut could dominate price action.

Key entities

  • WisdomTree, Inc.

    Discussed Q2 2026 performance, revised H2 interest income guidance, buyback plans, and tokenized ETF pipeline.

  • Atlantic House

    Integration focus for derivatives-based and outcome-oriented solutions, with potentially volatile structuring fees.

  • Ceres (Fund I and Fund II)

    Transition from Fund I to Fund II in June, affecting flow cadence and performance fee normalization.

Related articles

$WTMed

WisdomTree, Inc. (WT): Results of Operations and Financial Condition

WisdomTree, Inc. (WT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 WisdomTree Announces Second Quarter 2026 Results Record AUM of $162.9 Billion Diluted Earnings Per Share of $0.28; Adjusted Earnings Per Share of $0.31 13% Annualized Organic Flow Growth Rate Operating Margin Expanded by 780 bps Year over Year; or 900 bps, on an Adju

$WTMed

WisdomTree (NYSE:WT) Delivers Strong Q2 CY2026 Numbers

Asset management firm WisdomTree (NYSE: WT) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 57.3% year on year to $177.2 million. Its non-GAAP profit of $0.31 per share was 17.3% above analysts’ consensus estimates. Is now the time to buy WisdomTree? Find out by accessing our full research report, it’s free. "The second quarter demonstrated the quality of WisdomTree's growth.

$WTMedAI 8/10

WisdomTree (WT) Launches Physical AI, Humanoids, Drones ETF (WDRN) Focused on Real-World Automation

WisdomTree (NYSE:WT) launched the Physical AI, Humanoids, and Drones ETF (WDRN) on May 14, targeting companies applying AI to physical tasks. The fund has a 0.45% expense ratio and focuses on humanoid robotics, autonomous drones, smart manufacturing, and logistics automation, using a rules-based, quarterly rebalanced index. The report says it aims to track the shift from digital AI to real-world automation.

$HIMSHighAI 8/10

Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company

Hims & Hers (HIMS) CEO Andrew Dudum defended the company against an FTC lawsuit, citing its revenue growth and subscriber base. Q2 revenue rose 40% YoY to $753M, with a full-year forecast of $3.1B-$3.3B. However, margins fell to 64% from 76%, and free cash flow was negative $68M, raising concerns about profitability and legal risks.